Mylan
N.V. MYL today issued the following statement in response to the
report issued by Institutional Shareholder Services (ISS) regarding Mylan's
proposed acquisition of Perrigo Company plc PRGO. Mylan notes
that other leading proxy advisory firms, Glass Lewis and Egan-Jones, earlier
in the week issued reports recommending Mylan shareholders vote in favor of
the Perrigo transaction.
Mylan's Executive Chairman Robert J. Coury commented, "While today's report
from ISS repeatedly recognizes the clear industrial logic and solid business
strategy of combining Mylan and Perrigo, it misunderstands and/or
underestimates, without a meaningful basis, many other key aspects of the
transaction. In particular, ISS fails to comprehend the potential for medium
and long-term value creation for Mylan shareholders, the compelling synergy
opportunity, the potential for meaningful multiple expansion and the ability
to take advantage of the continuing consolidation in our industry.
"We are confident that acquiring Perrigo is the right next strategic step
for Mylan and its shareholders in continuing to deliver on our stellar track
record of creating significant and sustained value for our shareholders. As
ISS acknowledges, together Mylan and Perrigo will create a unique profile
within the industry with complementary businesses and unmatched scale in our
operations. Further, we will have one of the industry's broadest and most
diversified portfolios, and immense reach across distribution channels
around the world, allowing us to mean the most to our customers and
consumers. We remain firm that we expect at least $800 million of annual
pre-tax operational synergies by the end of year four, substantial free cash
flows and meaningful multiple expansion. Importantly, the diversity, size
and scale created by this combination will allow us to continue to be a
leading consolidator in our industry.
"We have spent a great deal of time talking to our shareholders about this
opportunity and remain extremely confident we will receive their support.
We note that Abbott Laboratories, our largest shareholder owning
approximately 14.25% of Mylan's outstanding shares, already has announced
its intention to vote in favor of the acquisition. We intend to launch our
offer to acquire Perrigo's ordinary shares after we receive the approval of
our shareholders at our upcoming extraordinary general meeting, and are even
more confident following the ISS report that Perrigo shareholders also will
recognize the compelling, value-enhancing opportunity in this combination."
Mylan recommends its remaining shareholders to vote "FOR" the proposal to
approve the Perrigo transaction described further in its definitive proxy
statement that has been filed with the SEC.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in